THE EFFECT OF REMIFENTANIL ON DESFLURANE REQUIREMENTS FOR SYMPATHETIC RESPONSES TO SURGICAL INCISION.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2004-004287-71-IT

Enrollment

Unknown

Registered

2005-03-08

Start date

2004-10-22

Completion date

Unknown

Last updated

2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DESFLURANE APPLICATION MedDRA version: 6.1 Level: SOC Classification code 10042613

Interventions

Trade Name: ULTIVA 1*IV 5 FL 1 MG Product Name: NA Product Code: NA Pharmaceutical Form: Solution for infusion INN or Proposed INN: Remifentanil CAS Number: 132539-07-2 Concentration unit: mg milligra

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026